Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Nicorandil to Reduce Cardiac Death After Coronary Revascularization in Hemodialysis Patients: A Randomized Trial

NCT00848562 is registered in ClinicalTrials.gov with Toujinkai Hospital as lead sponsor.

NCT NCT00848562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00848562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Nicorandil to Reduce Cardiac Death After Coronary Revascularization in Hemodialysis Patients: A Randomized Trial
Lead sponsor
Toujinkai Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2002
Completion date
December 31, 2006
Enrollment
129 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, congestive heart failure